A detailed history of Steadtrust LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Steadtrust LLC holds 2,070 shares of ABT stock, worth $269,162. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,070
Previous 1,951 6.1%
Holding current value
$269,162
Previous $265 Million 4.46%
% of portfolio
0.19%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Dec 02, 2025

BUY
$120.51 - $136.62 $14,340 - $16,257
119 Added 6.1%
2,070 $277 Million
Q2 2025

Dec 01, 2025

BUY
$123.95 - $138.08 $241,826 - $269,394
1,951 New
1,951 $265 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Steadtrust LLC Portfolio

Follow Steadtrust LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steadtrust LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steadtrust LLC with notifications on news.